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Hyperosmolality, acetate, and lactate: Dilatory factors during peritone.
al dialysis. Factors that alter peritoneal blood flow may influence the
clearance of solutes during peritoneal dialysis. Arteriolar vasodilation,
for instance, could increase the delivery of solutes to the capillaries and
venules leading to an increase in solute transport into the peritoneal
cavity. This study was designed to identify the vasoactive effects of
several major components of McGaw5 and Dianeal peritoneal dialysis
solutions to understand how the composition of these solutions may
alter in vivo blood flow in the peritoneum. Because the major differ-
ences between these solutions and Krebs solution are a high osmolality,
a high dextrose concentration, and an acetate or lactate buffer system,
we investigated the effects of these components. Rats were anesthe-
tized with a combination of urethane and chioralose. The cremaster
muscle, with the nerve and blood supplies from the rat still intact, was
placed in a specially designed tissue chamber that was filled with Krebs
solutions. A port permitted microscopic observations of the blood
vessels. In vivo television microscopy was used to quantitate changes
in small arteriole diameters induced by changes in the composition of
the solution bathing the cremaster or by the addition of nitroprusside.
Hyperosmolality produced by the addition of dextrose, sucrose, or
sodium chloride to the Krebs solution induced a submaximal dilation of
the small arterioles of the cremaster. The rate of dilation differed
depending on the substance used to increase osmolality. A normal
osmolality acetate (74 mM) or lactate (45 mM) solution produced a slow,
submaximal dilation of the cremaster arterioles. Hyperosmolar acetate
(37 or 74 mM) or lactate (45 mM) solutions produced a rapid, maximal
dilation of these vessels. Because the rate of dilation and maximal effect
produced by the commercial dialysis solutions were similar to these
same parameters produced by the high-osmolality acetate or lactate
solutions, the dilatory effects of McGaw® and Dianeal® solutions
appear to be due to the combinations of high osmolality and the buffer
anion acetate or lactate.
Hyperosmolalite, acetate, et lactate: Facteurs vasodilatateurs au cours
de Ia dialyse péritonéale. Les facteurs qui modifient le debit sanguin
péritonéal peuvent influencer Ia clearance des substances dissoutes au
cours de Ia dialyse péritonéale. La vasodilatation artériolaire, par
exemple, peut augmenter le debit de substances dissoutes aux capil-
laires et auxveinules, ce qui peut augmenter le transport de substances
dissoutes dans Ia cavité péritonéale. Ce travail a pour but d'identifier les
effets vasoactifs de plusieurs constituants importants des solutions de
dialyse péritoneale McGaw® et Dianeal® de facon a comprendre
comment Ia composition de ces solutions peut modifier in vivo le debit
sanguin dans le péritoine. Puisque les differences majeures entre ces
solutions et le Krebs sont une osmolalité élevde, une grande concentra-
tion de dextrose et un système tampon acetate lactate, nous avons
étudié les effects de ces composants. Des rats ont etC anesthésiés avec
un mélange d'urCthane et de chloral. Le muscle cremaster avec le neil
et le pCdicule vasculaire intacts ont etC places dans une chambre
spécialement construite et remplie de Krebs. Une fenétre permet
l'observation microscopique des vaisseaux. Un système de tClCvision a
ete utilisé pour quantifier les modifications des diamètres des petites
artères dCterminCes par les changements de composition de Ia solution
baignant le cremaster ou par l'addition de nitroprussiate. L'hyperosmo-
lalitC produite par l'addition de dextrose, sucrose ou chlorure de sodium
au determine une dilatation sous-maximale des petites arterioles du
cremaster. La vitesse de dilation vane avec Ia substance utilisée pour
determiner l'augmentation d'osmolalite. Une solution d'osmolalitC nor-
male d'acCtate (74 mM) ou de lactate (45 mM) produit une dilatation
lente, sous-maximale des arterioles du cremaster. Des solutions hyper-
osmolaires d'acétate (37 ou 74 mM) ou de lactate (45 ms'i) produisent
une dilatation rapide et maximale. Puisque Ia vitesse de dilatation et
l'effet maximal produit par les solutions de dialyse du commerce sont
semblables ace qui est obtenu avec des solutions d'acétate ou de lactate
d'osmolalité ClevCe, l'effet vasodilatateur des solutions McGaw5 et
Dianeal parait ètre dñ a Ia combinaison de l'osmolalite ClevCe et du
tampon acetate ou lactate.
Recently, we demonstrated that commercial solutions for
human peritoneal dialysis produce a transient constriction,
which is followed by a prolonged dilation when these solutions
are topically applied to arterioles of the rat cremaster muscle
[1]. If there are similar vasoactive effects of these solutions in
humans, there could be altered clearances of solutes during
clinical peritoneal dialysis [1,21. The peritoneal dialysis solu-
tions differ from nonvasoactive bicarbonate-buffered Krebs
solutions by having a high osmolality due to dextrose and an
acetate or lactate buffer system. Any of these factors could be
responsible for the vasoactive effects of peritoneal dialysis
solutions.
In general, hyperosmolality produces vasodilation in various
vascular beds. Hyperosmolar sucrose solutions abolish the
electrical and mechanical activity of rat portal veins [3,4], and
they dilate arterioles in the hamster cheek pouch and cremaster
muscle [5]. Hyperosmolar solutions of dextrose and sodium
chloride decrease perfusion pressure in the dog forelimb [61 and
in the cat ileum [71. In one of only a few studies on the in vitro
vasoactive effects of acetate and lactate, we [81 have shown that
the effect of these anions on the mesenteric ring is a transient
contraction followed by a more prolonged relaxation. Because
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Table 1. A summary of the major constituents (mM) for the control Krebs and experimental solutions
Solution, — mOsm NaC1 NaHCO3 Dextrose Acetate Lactate Sucrose
I. Krebs-control (290) 118.5 19.9 11.6 — — —
II. Krebs-dextrose (360) 118.5 19.9 83.3 — — —
III. Krebs-dextrose (290) 80.9 19.9 83.3 — — —
IV. Krebs-sucrose (360) 118.5 19.9 11.6 — 71.7
V. Krebs-sodium chloride (360) 153.5 19.9 11.6 — — —
VI. Krebs-acetate (360) 118.5 19.9 11.6 36.9 — —
VII. Krebs-2X acetate (360) 76.9 19.9 11.6 74.4 — —
VIII. Krebs-2X acetate (290) 46.2 19.9 11.6 74.4 — —
IX. McGaw® (360) 95.7 — 83.3 45.0 — —
X. Krebs-lactate (360) 118.5 19.9 11.6 — 45.0 —
XI. Krebs-lactate (290) 68.6 19.9 11.6 — 45.0 —
XII. Dianeal® (360) 96.0 — 83.3 — 45.0 —
Liang and Lowenstein [9] and Molnar Ct a! [10] have demon-
strated in perfusion experiments that acetate infusion wilt
increase blood flow in a number of tissues, including skeletal
muscle, the predominate in situ effect of acetate appears to be
vasodilation.
In our present studies, we have made direct microscopic
observations of in vivo arterioles in the rat cremaster muscle.
This tissue is a skeletal muscle that is thin enough to be used for
transmitted-light microscopy. It is an extension of the abdomi-
nal wall muscles and is thus a model for parietal peritoneum. In
these experiments, we have quantitated maximum arteriolar
dilation and the rate of dilation to determine the relative
vasoactive properties of hyperosmolality, dextrose, acetate,
lactate, and two commercial peritoneal dialysis solutions, 1.5%
dextroseMcGaw®, and 1.5% dextrose Dianeal®. These studies
are important because they define some of the factors in
peritoneal dialysis solutions that could be altered to produce
predictable changes in small solute clearances via changes in
peritoneal blood flow during human peritoneal dialysis.
Methods
Sprague-Dawley rats (134 to 158 g in body wt) were anesthe-
tized with an i.p. injection of a combination of c-chloralose (60
mg/kg) and urethane (800 mg/kg). The cremaster muscle prepa-
ration that we used has been described previously [11]. Basical-
ly, the right cremaster was exposed, slit along its midline, and
spread with sutures over a cover glass in the bottom of a 60-mi
plexiglass bath. The nerves and the circulation from tFe animal
to the cremaster remained intact. The bath was filled with a
modified Krebs solution containing sodium chloride (118.5
mM), sodium bicarbonate (19.9 mM), dextrose (11.6 mM),
potassium chloride (4.7 mM), calcium chloride 2H20(2.6 mM),
monobasic potassium phosphate (1.2 mM), and magnesium
sulfate 7H20 (1.2 mM). Bath temperature (34.5° C), pH (7.4),
Po2 (30 to 40 mm Hg) and Pco2 (40 mm Hg) were continuously
controlled. The rat was positioned on a microscope stage so
that light was passed through the cover glass and cremaster
muscle and into the microscope objective lens to provide
images of small arterioles (7 to 16 p.m in diameter). Closed-
circuit television microscopy was used to visualize these ves-
sels, and their diameters were measured every 30 sec on the
television monitor with a millimeter ruler. Mean arterial blood
pressure was continually measured through a femoral artery
cannula, and heart rate was recorded every minute via s.c.
needle electrodes. Rectal temperature was maintained at ap-
proximately 370 C by a small heating pad placed under the
animal,
In the first series of experiments, 12 solutions with different
compositions were used to determine the vasoactive effects of
osmolality, dextrose, sodium acetate, and sodium lactate (Table
I). Osmotic effects were assessed by using modified Krebs
solutions, which were made hypertonic (to approx. 360 mOsm)
by the addition of dextrose, sucrose, or sodium chloride (com-
parison of solutions I, II, IV, and V in Table 1). Osmolality of
each solution was measured with a Precision System osmome-
ter. The effect of dextrose alone was evaluated by substitution
of dextrose for sodium chloride (comparison of solutions I and
III) to maintain solution osmolality near that of the Krebs
solution (approx. 290 mOsm).
Our past studies on isolated mesenteric arteries [8] have
indicated that maximal relaxant effects of sodium acetate occur
at a concentration between 30 and 100 mM. In our present
studies, we used McGaw® dialysis solution, which contained 45
m acetate and had an osmolality of approximately 360 mOsm.
The experimental Krebs solutions we used also had an osmolal-
ity of 360 mOsm and sodium acetate concentrations of 37
(solution VI) or 74 m (solution VII) for comparison to the
effects of McGaw dialysis solution (solution IX). Solution VII
was designed to contain a maximally effective concentration of
acetate [81, Solution VI had a concentration of acetate and an
osmolality that were similar to that found in McGaw® dialysis
solution. To determine the effects of acetate alone, we com-
pared a Krebs solution having 74 mM acetate and a normal
osmolality of 290 mOsm (solution VIII) with our control Krebs
(solution I). Our studies on the isolated mesenteric artery [8]
indicated that relaxant effects of sodium lactate were maximal
at the concentration found in Dianeal® solutions (45 mOsm).
Thus, we compared Dianeal® (solution XII) with an experimen-
tal Krebs solution at the same osmolality and lactate concentra-
tion (solution X) and with a Krebs solution at normal osmolality
but also containing 45 m sodium lactate (solution XI).
The basic protocol for all of these experiments consisted of a
5-mm control period with our normal Krebs solution in the
cremaster bath followed by a 10-mm period with one of the
experimental solutions in the bath. Subsequent bath changes
with our control Krebs solution returned vascular diameters to
the control values, and the sequence was repeated with another
experimental solution. A maximum of four experimental solu-
tions was used in each animal experiment. The order of the
application of the solutions was varied in different experiments.
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In the second series of experiments, concentration-response
curves to sodium nitroprusside were obtained to determine the
maximum dilated state of the rat cremaster arterioles. After a 5-
mm control period with Krebs solution (solution I) in the
cremaster bath, nitroprusside was added, and the effect was
observed for 5 mm. The bath was then drained, and a fresh
Krebs solution and a higher concentration of nitroprusside were
added to the bath. Threefold increases in the concentration of
nitroprusside in the bath were used until a maximal dilatory
response was reached (no further dilation). After a 20-mm
recovery period, during which the bath was changed several
times with fresh Krebs, a second complete concentration-
response curve to nitroprusside was completed for each arteri-
ole. These concentration-response curves were graphically
analyzed to determine the maximal arteriolar diameter for
nitroprusside-induced dilation, and to obtain pD2 values (the
negative logarithm of the concentration of drug that will pro-
duce 50% of the maximal response; —log ED50) as measures of
arteriolar sensitivity to nitroprusside [12].
The mean arteriolar diameter during the period with the
control Krebs solution in the bath was compared with the
maximal arteriolar diameter during exposure of the cremaster to
each of the experimental solutions. Analysis of variance and a
Duncan's new multiple-range test with correction for unequal
sample size [13] were used to identify specific differences
among the various arteriolar responses to the different solu-
tions. A statistical level of P 0.05 was used to establish
significant differences.
Dilation rate constants (K) for the change in arteriolar
diameter in response to the experimental solutions were deter-
mined by fitting the experimental data to an asymptotic expo-
nential model (y = M — Aet). In this equation, the response
at time "t" is symbolized by "y," and the maximal response is
symbolized by "M." "A" is a scaling parameter in the regres-
sion model that allows curves with different rate constants to
have different Y intercepts. Estimates of the model parameters
M, A, and K were calculated by the weighted Gauss-Newton
method [14] for the arteriolar response to each solution. A
statistical analysis was obtained by comparing the total sum of
squared residuals resulting when the model included separate
rate constants for two groups, with the case in which the model
constrained the two groups to share a common rate constant.
Graphic examples of this analysis for two groups (solutions V
and VIII) are shown in Fig. I. The dashed lines represent the
mean arteriole diameter at each point in time after the applica-
tion of the experimental solution. The solid line represents the
best fit of the data to our model (y = M — Ae_(t). A modified F
test was used to determine if there was a significant reduction in
the total sum of squared residuals [15]. If the reduction was
significant (P < 0.01), the rate constants were considered to be
significantly different for the two groups under consideration.
Results
In the first series of experiments, the 11 experimental solu-
tions produced different degrees of arteriolar dilation compared
with the control Krebs solution. All high-osmolality solutions
produced marked dilation of cremaster arterioles (for an exam-
ple, see Fig. 1, lower panel). Fig. 2 compares the mean
arteriolar diameters (hatched bars) in the control Krebs solution
(solution I) with the maximal arteriolar diameter during the
ifs - 10
Krebs-sodium chloride
(356± 1.6mOsm)
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Time, mm
Fig. 1. Two examples of the lime-course analysis for dilation rate
constants. In each panel, the dashed line represents the experimental
mean arteriolar diameters (mean SEM) at each point in time during
exposure of the cremaster to the experimental Krebs solution. The solid
line is the statistically best fit curve of the data to the model Y =MAe'. In these examples, the Krebs-acetate solution produces a
greater dilation (approx. 5 to 18 p.) than does the sodium chloride
solution (approx. 5 to 12 p.), but the sodium chloride solution dilated at a
faster rate (1.05 0.27 vs. 0.09 0.05 for the acetate solution).
exposure of the cremaster to various Krebs solutions made
hyperosmotic by the addition of dextrose, sucrose, or sodium
chloride (open bars). There was a significant dilation with each
of the high-osmolality solutions, and the magnitude of dilation
was similar for each solution. The Krebs solution with a high
dextrose concentration at normal osmolality (solution III) did
not produce dilation.
All Krebs-acetate solutions used produced marked dilation of
the cremaster arterioles (Fig. 1, top panel). Fig. 3 compares the
mean arteriolar diameters for the control Krebs solution
(hatched bars) with the maximal arteriolar diameters for the
three Krebs-acetate solutions, as well as for the McGaw
dialysis solution (open bars), which also contained acetate, The
maximal dilation produced by the high osmolality Krebs-ace-
tate solutions (VI and VII) and the McGaw® solution (IX) were
all similar. At a normal osmolality, Krebs-acetate (solution
VIII) did not produce as great a dilation (P < 0.05) as that
produced by the combination of acetate and high osmolality
(solution VII).
The three solutions containing 45 m sodium lactate all
produced dilation of the cremaster arterioles (Fig. 4). Dianeal®
(solution XII) and solution X, both of which were at a high
osmolality, produced a greater dilation than did solution XI,
which had the same concentration of sodium lactate but a
normal osmolality. There were no significant differences in
maximal effects between any of the solutions with a high
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Fig. 2. Effect of high osmolality and dextrose on arteriolar diameters.
The hatched bars represent the mean arteriolar diameters (mean sEM)
for exposure of the cremaster to our control Krebs solution (290
mOsm). The open bars represent the maximal arteriolar diameter
during cremaster exposure to four different modified Krebs solutions.
The major consituent added to each Krebs solution and the solution
osmolality are listed below each pair of bars. The Roman numeral
within each bar refers to the solution description in Table I, and the
number in parentheses gives the number of rats for each group. An
asterisk above the bar indicates that the experimental solution gave a
significant dilation in comparison to the control Krebs solution (P <
0.05).
osmolality and sodium acetate (solutions VI, VII, and IX) and
the solutions with a high osmolality and sodium lactate (solu-
tions X and XII).
In the second series of experiments, topical application of
nitroprusside to the cremaster produced dilation of arterioles
with no effect on mean arterial blood pressure or on heart rate.
Data for the maximal arteriolar diameters and for pD2 values
(—log ED50) are shown in Table 2. There appeared to be a slight
decrease in sensitivity (a decrease in the pD2 value) for the
second concentration-response curve compared with the first,
(pD2 = 6.5 0.1 vs. 6.2 0.2), but this difference was not
significant (paired t test). Maximal dilation of these arterioles in
response to nitroprusside was the same for both the first (from a
control of 10.5 0.7 to 21.9 2.5 m) and second (from a
control of 10.7 0.8 to 23.2 2.4 p.m) curves. The average
concentration that produced the maximal response (l0- M)
was used for the subsequent determination of the rate constant
of dilation for nitroprusside.
Dilation produced by the experimental solutions started
shortly after exposure of the cremaster and was maintained
until the bath solution was changed to our control Krebs
solution, which returned the vessels to near control diameter.
The results of our analysis of the dilation rate constants for the
various Krebs-experimental solutions are given in Table 3.
Although the maximal effects of the high osmolality solutions in
Fig. 2 were similar, the dilation rate constants were considera-
bly different (Table 3). The dilation rate constant produced by
the high osmolality sodium chloride (V) Krebs solution (1.05
0.27) was significantly faster than the dilation rate constant for
the high osmolality Krebs-dextrose (II) solution (0.21 0.06).
The dilation rate constant for the high osmolality Krebs-sucrose
(IV) solution was intermediate (0.43 0.13).
*
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Fig. 3. Effect of high osmolality and acetate on arteriolar diameters.
The hatched bars represent the mean arteriolar diameters (mean sEat)
for exposure of the cremaster to the control Krebs solution (290
mOsm). The open bars represent the maximal arteriolar diameter
during exposure to an experimental Krebs solution or to McGaw®
peritoneal dialysis solution. The major constituent added to each Krebs
solution and the solution osmolality in each group are given below the
pairs of bars. McGaw® peritoneal dialysis solution contained 45 mM
acetate. The Roman numerals refer to the solution description in Table
1 and the number in parentheses gives the number of rats for each
group. An asterisk above the bar indicates a significant difference from
control (P < 0.05).
The dilation rate constant for the Krebs solution containing
74 mt'i acetate at high osmolality (VII, 0,45 0.07) was
significantly greater than that for the solution with the same
concentration of acetate but at a normal osmolality (VIII, 0.09
0.05). The high osmolality solution with the lower concentra-
tion of acetate (VI) (37 mM) gave a rate constant of dilation (0.52
0.08) that was similar to that for the Krebs solution with the
higher acetate concentration (VII). The maximal arteriolar
dilation in response to McGaw® dialysis solution (25.1 0.03
lim) and the dilation rate constant of this solution (0.54 0.11)
were not different from the maximal arteriolar dilation and
dilation rate constants of either of the high-osmolality Krebs
acetate solutions (VI or VII).
Rate constants for the Krebs solutions containing sodium
lactate also differed depending on the osmolality. The high-
osmolality sodium lactate Krebs solution (X) had a rate con-
stant (0.67 0.19) which was greater than that of the normal
osmolality sodium lactate Krebs solution (XI), 0.13 0.12.
Although the maximal effect of Dianeal® was similar to that of
the high-osmolality lactate Krebs solution, the rate constant of
dilation for Dianeal® 0.12 0.07, was similar to that of the
normal-osmolality lactate Krebs solution. The vasodilator ni-
troprusside produced a maximal dilation similar to that pro-
duced by McGaw® and Dianeal® dialysis solutions and the high-
osmolality acetate and lactate solutions. But, the dilation rate
constant produced by a maximally effective concentration of
nitroprusside (10—s M) was approximately four times as large
(2.17 0.63).
Discussion
Previous microcirculatory experiments from our laboratory
have shown that commercial peritoneal dialysis solutions are
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Table 2. Effects of sodium nitroprusside on the rat cremaster
arteriolea
*
XI
(8)
Lactate
45mM
(281 1 mOsm)
Control
arteriole diameter
pm
Sodium nitroprusside
Maximal arteriole
diameter
p.m
Arteriole pD2'
-log ED0
First curve
Second curve
10.5 0.7
10.7 0.8
21.9 2.5
23.2 2.4
6.5 0.1
6.2 0.2
*
XI
(7)
D laneal®
(347 mOsm)
Values are the means SEM for 9 animals.
bThepD2 is negative logarithm of the conc. of drug that will produce
50% of the maximal response.
Table 3. Dilation rate constants are given for the effects of the
experimental solutions on arterioles in the rat cremaster musclea
Experimental solution
Rate constant"
sec'
II. Krebs-dextrose (360 mOsm, 83 mM) 0.21 0.06
IV. Krebs-sucrose (360 mOsm, 72 mM) 0.43 0.13
V. Krebs-sodium chloride (360 mOsm, 154 mM) 1.05 0.27
VI. Krebs-acetate (360 mOsm, 37 mi) 0.52 0.08
VII. Krebs-acetate (360 mOsm, 74 mi) 0.45 0.07
VIII. Krebs-acetate (290 mOsm, 74 mrvi) 0.09 0.05
IX. McGaw® (360 mOsm, 45 mti acetate) 0.54 0.11
X. Krebs-lactate (360 mOsm, 45 msi) 0.67 0.19
XI. Krebs-lactate (290 mOsm, 45 mrs) 0.13 0.12
XII. Dianeal® (360 mOsm, 45 mti lactate) 0.12 0.07
Sodium nitroprusside in control Krebs (290 mOsm) 2.17 0.63
OLi]
Lactate
45mM
(360 2 mOsm(
Fig. 4. Effect of high osmolality and lactate on arieriolar diameters.
The hatched bars represent the artenolar diameters (mean 5EM) for
exposure of the cremaster to the control Krebs solution (290 mOsm).
The open bars represent the maximal arteriolar diameter during expo-
sure to an experimental Krebs solution or the Dianeal® peritoneal
dialysis solution. The major constituent added to each Krebs solution
and the solution osmolality in each group are given below the pairs of
bars. Dianeal® peritoneal dialysis solution contained 45 m lactate. The
Roman numerals refer to the solution description in Table I, and the
number in parentheses gives the number of rats for each group. An
asterisk above the bar indicates a significant difference from control (P
< 0.05).
vasoactive [1, 16]. In the rat cremaster muscle, these commer-
cial solutions produce a transient arteriolar constriction that
lasts 1 to 4 mm followed by a more prolonged dilation. These
commercial solutions differ from Krebs solution in that they use
an acetate or lactate buffer instead of a bicarbonate buffer
system, they have a high osmolality (approx. 360 mOsm vs. 290
mOsm in Krebs) produced by a high dextrose concentration,
and they have a low pH (approx. 5.5 vs. approx. 7.4 pH of
Krebs solution). The low pH of commercial solutions does not
account for the vasoactive properties of peritoneal dialysis
solutions, and it does not appear to alter the solute clearances
that can be obtained with peritoneal dialysis in humans [1, 16].
In our current study, we investigated the microvascular effects
of osmolality, dextrose, acetate, and lactate, as well as the
combination of the buffer anion (acetate or lactate) and high
osmolality as are found in McGaw® and Dianeal® dialysis
solutions.
In these in vivo experiments, which involved direct micros-
copy for observations of small arterioles, Krebs solutions made
hyperosmolar (—360 mOsm) by the addition of dextrose, su-
crose, or sodium chloride dilated the cremaster arterioles from
a control diameter of approximately 7 to diameters between
14 and 18 .t. There were no significant differences among the
maximal effects (Fig. 2) for these three hyperosmolar Krebs
solutions. But, there were differences in the dilation rate
constants (Table 3) among these three solutions. The dilation
rate constant (1.05 0.27) for a high osmolality sodium chloride
solution (V) was significantly greater than that (0.21 0.06) for
the high osmolality dextrose solution (II). Other investigators
have used the perfused dog forelimb [6] and the perfused cat
ileum [7] and also found that the magnitude and time course of
the dilatory effects of hyperosmolar dextrose and sodium
a Results are the means SEM.
b P < 0.01 (for solutions II vs. V, VI vs. VIII, VII vs. VIII and VIII
vs. IX)
chloride solutions differed. Generally, in these perfusion experi-
ments, sodium chloride produced a larger but more transient
decrease in perfusion pressure.
Previous investigators have postulated that the vascular
effects of hyperosmolality may be only partially but not wholly
due to an effect on cell volume [18, 19]. Our data show rate
constants of dilation and maximal effects that depend on the
substance used to increase osmolality but not on the relative
permeability of that substance through the vascular wall as
reported by Landis and Pappenheimer [20]. Thus, our data
suggest that multiple mechanisms may be present for the
vasodilatory effects of hyperosmotic solutions.
Mellander et al [3] failed to find a vascular effect of a high-
dextrose normal-osmolality solution. In our experiments, a
high-dextrose, normal-osmolality solution (Fig. 2) also failed to
produce dilation, suggesting that the observed dilation to the
high-osmolality, high-dextrose Krebs solution was due to the
higher osmolality of this solution and not to some other effect of
dextrose. On the other hand, the maximal dilation with the
hyperosmolar solution (Fig. 2) was less in our experiments than
that obtained with McGaw® or Dianeal® peritoneal dialysis
solutions (Figs. 3 and 4). Thus, our data indicates that high
osmolality alone can not totally explain the vasodilatory effects
of commercial peritoneal dialysis solutions.
High-osmolality Krebs solutions with 37 m acetate, 74 mM
acetate, or 45 m lactate produced the same maximal dilation
as did McGaw® and Dianeal® peritoneal dialysis solutions, and
as did nitroprusside. This suggests that all of these solutions
maximally dilated the small cremaster arterioles. These data
also indicate that the 45 m acetate that is present in McGaw®
dialysis solution is a supramaximal concentration for dilation of
the small arterioles. We reached a similar conclusion with in
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vitro studies of the rat mesenteric artery [8]. On the other hand,
our present in vivo cremaster studies also demonstrate that a
normal-osmolality solution with either a high acetate or high
lactate concentration does not produce as much dilation as does
a high-acetate or -lactate, high-osmolality Krebs solution (Figs.
3 and 4). Thus, it appears that a maximally effective concentra-
tion of these buffer anions will not by themselves produce
maximal dilation of the small cremaster arteriole. Collectively,
these data indicate that the vasodilatory effects of McGaw® and
Dianeal® dialysis solutions are produced by the combination of
the high osmolality and the buffer anion (acetate and lactate,
respectively) found in these solutions.
The dilation rate constant (Table 3) for the normal-osmolality
Krebs-acetate (74 mM) solution (0.09 0.05) was substantially
smaller than that for the high-osmolality Kreb s-acetate (74 mM)
solution (0.45 0.07). Similarly, the dilation rate constant for
the normal-osmolality Krebs-lactate (45 mM) solution, 0.13
0.12, was substantially smaller than that for the high-osmolality
Krebs lactate solution, 0.67 0.19. These data in combination
with the fast dilation rate constant for nitroprusside (2.2 0.63)
suggest that the mechanism for acetate- and lactate-induced
arteriolar dilation may be a considerably slower developing
indirect mechanism for an effect on vascular smooth muscle
versus a more rapid and more direct mechanism for a pharma-
cologic agent such as nitroprusside. Other investigators have
suggested that acetate may produce vascular dilation by meta-
bolic conversion of acetate to the vasodilator AMP [9] or by
conversion to other vasodilatory intermediary metabolites [211.
Our data on dilation rate constants for acetate, lactate, and
nitroprusside are consistent with the possibility that the acetate-
and lactate-induced dilation of the small arterioles in skeletal
muscle may occur via a metabolite of these anions rather than a
direct effect.
The maximal effect of the Dianeal® dialysis solution was
similar to that of the high-osmolality Krebs-lactate solution
(Fig. 4). Thus, it appears that the dilatory effect of Dianeal®
may be due to the combined effects of high osmolality and the
lactate buffer. The rate constant for dilation of the Dianeal®
solution was similar, however, to that of the normal-osmolality
Krebs-lactate solution (Table 3). This suggests that an addition-
al factor may be present in Dianeal® which retards the dilatory
component of this solution. Although we have previously
determined that the low pH of dialysis solution does not effect
the maximal response [1], a low pH in a lactate-buffered
solution could be a candidate for decreasing the rate of dilation.
The dilation rate constant (Table 3) for the McGaw® dialysis
solution (0.54 0.11) was similar to those for the two high-
osmolality, acetate-Krebs solutions (0.52 0.08 and 0.45
0.07). The dilation rate constant and the magnitude of arteriolar
dilation for the McGaw® dialysis solution were significantly
greater than those for the normal-osmolality, high-acetate
Krebs solution (VIII). Collectively, our data strongly support
the conclusion that the steady-state dilatory effects of McGaw®
and Dianeal® solutions are primarily if not solely due to the
combination of the high-osmolality and buffer-anion (acetate or
lactate) components of these commercial peritoneal dialysis
solutions.
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